Carta Revisado por pares

No red cell resistance to NO? I think not!

2010; American Physiological Society; Volume: 108; Issue: 5 Linguagem: Inglês

10.1152/japplphysiol.00240.2010

ISSN

8750-7587

Autores

Gerald S. Zavorsky,

Tópico(s)

Neonatal Respiratory Health Research

Resumo

INVITED EDITORIALSNo red cell resistance to NO? I think not!Gerald S. ZavorskyGerald S. ZavorskySchool of Medicine, Saint Louis University, Saint Louis, MissouriPublished Online:01 May 2010https://doi.org/10.1152/japplphysiol.00240.2010This is the final version - click for previous versionMoreSectionsPDF (101 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat pulmonary capillary blood volume and alveolar-membrane diffusing capacity are components to overall pulmonary diffusing capacity. The equation deriving pulmonary diffusing capacity into these components was first published in 1957 by Francis Roughton and Robert Forster (19) in which the total resistance to pulmonary diffusion is the addition of alveolar-membrane resistance and red blood cell resistance placed in series, such that 1DL=1DM+1ΘVC where, DL is the overall diffusing capacity of the lung, DM is the true alveolar-membrane diffusing capacity separating the alveolar air from the blood, Vc is the total volume of blood in the pulmonary capillaries exposed to alveolar air, and Θ is the number of milliliters of gas taken up by red blood cells in 1 ml of blood per 1 mmHg gradient of partial pressure of dissolved gas between the plasma and the interior of the red blood cell. While technically difficult to measure pulmonary diffusing capacity for oxygen, carbon monoxide (CO) is most commonly used as a surrogate of oxygen transfer. Therefore, DL and DM are reported as DMCO (alveolar-membrane diffusing capacity for CO) and DLCO (pulmonary diffusing capacity for CO) while Θ is reported as ΘCO (the blood transfer conductance for CO). According to the Roughton and Forster equation (19), the resistance of the red blood cell to the uptake of CO is about equal to the resistance of the alveolar-capillary membrane to the diffusion of gas across it.To obtain DMCO and Vc, DLCO has been traditionally measured at two different levels of alveolar Po2 (PaO2), e.g., at ∼100–120 mmHg and ∼600 mmHg. For each PaO2 level, 1/DLCO is plotted on the y-axis and 1/ΘCO is plotted on the x-axis. A line is drawn through the two points and the y-intercept (1/DMCO) and slope (1/Vc) can be solved. The formula for 1/ΘCO varies across studies, but the most predominant formula used in studies today are from the original Roughton and Forster paper or a modification of this formula (12, 19).However, there are at least three main technical issues with this traditional two-step method in obtaining DMCO and Vc. First, at least four tests are needed (2 at low and 2 at high PaO2) to obtain a reliable measure of DMCO and Vc. This places considerable time restraint in a clinical setting and increases patient effort. Second, with the traditional method, the CO gas distribution in the lungs may be different at two inspirations at two different oxygen tensions, affecting DMCO and Vc. Third, with the standard method, cardiac output may vary between measurements of DLCO at different oxygen tensions, which then have to be interpolated to obtain DLCO at the two oxygen tensions at the same cardiac output. This would also affect DMCO and Vc.In 1983, Colin Borland and his colleagues (3) examined the fate of inhaled NO, as it was an important component of cigarette smoke. They determined that nitric oxide (NO) uptake behaved similarly to CO uptake such that the ratio of pulmonary diffusing capacity for NO (DLNO) to DLCO was ∼4.6, and concluded inhaled NO does not readily convert to nitrogen dioxide (NO2), a toxic gas (11, 21).1 Later, in 1987, Hervé Guénard et al. (13) made the assumption that since the reaction on NO with hemoglobin is effectively infinite, the blood transfer conductance for NO (ΘNO) must also be infinite (13). Therefore, as the diffusivity of NO is about twice that of CO (DLNO = DMNO ≈ 2 DMCO), Guénard assumed that DMCO and Vc could be calculated using a one-step maneuver in which both CO and NO are inhaled together. This was an ingenious idea. Hence, all the technical issues with the traditional Roughton and Forster two-step method are avoided with the new modified, one-step DLNO-DLCO technique. Since 1987, most studies that use this modified technique have assumed that ΘNO approaches infinity.Nonetheless, a disagreement soon arose whether DLNO = DMNO (2, 6). Colin Borland and colleagues believed that ΘNO was less than finite, at ∼4.5 ml NO·(ml blood·min·mmHg)−1. This was derived from a value obtained in vitro with human red blood cells in 1958 in unphysiological conditions (8). In 2006, Borland and colleagues used a membrane oxygenator as a model for NO and CO transfer (5). Their membrane oxygenator tests various factors that affect NO and CO in physiological conditions that would be impossible to do in vivo or in an isolated lung preparation. The authors postulated that if DLNO = DMNO then hemolysis (which eliminates red blood cell resistance) would not alter DLNO. However, hemolysis actually increased DNO, providing evidence that there is significant red blood cell diffusive resistance to NO (i.e., DNO<DMNO). A limitation of this study was that the results were neither obtained in human blood nor were they obtained in vivo.In this issue of the Journal of Applied Physiology, Colin Borland and colleagues (7) go one step further in that they use both in vitro (membrane oxygenator perfused with whole blood) and in vivo (foxhounds) data directly to examine whether ΘNO was infinite. They postulated if that there was significant red blood cell resistance to NO, both in vitro DNO and in vivo DLNO would increase progressively as red blood cells were replaced with cell-free heme-based blood substitute (cell-free hemoglobin-based oxygen carrier). Both in vitro and in vivo replacement of whole blood with hemolyzed blood and a cell-free hemoglobin solution (see Fig. 1) caused DLNO to progressively increase, implying that DLNO<DMNO. The in vitro and in vivo data demonstrate a finite ΘNO of ∼4.5 ml NO·(ml blood·min·mmHg)−1, similar to data from 1958 (8). Borland and colleagues further demonstrate that the overall resistance to pulmonary NO uptake (1/DLNO) is 63% alveolar-capillary membrane resistance (1/DMNO) and 37% red blood cell resistance (1/ΘNO·Vc) (7).Fig. 1.Percentage increase in 3 variables: diffusing capacity for NO (DLNO), the ratio of DLNO-to-DLCO, and diffusing capacity for CO (DLCO) between baseline and after successive exchange transfusion (30 ml/kg) with Oxyglobin solution (cell-free hemoglobin-based oxygen carrier) in 3 foxhounds [28.3 (SD 1.0) kg]. The percentage increase in DLNO and the ratio of DLNO-to-DLCO compared with baseline is statistically significant (P < 0.05). PaO2, PaCO2, and heart rate were maintained at ∼140 mmHg, 35 mmHg, and 110 beats/min, respectively, while [Hb] and arterial oxygen content (CaO2) decreased from 13.5 (1.5) to 11.4 (0.3) g/dl and 18 to 14 ml/dl, respectively, after exchange transfusion of Oxyglobin (Oxyglobin has a [Hb] content of 13 g/dl). The reduction in [Hb] and CaO2 with Oxyglobin is likely due to its known plasma expanding effect. By removing 850 ml of red blood cells from the foxhounds and then replacing 850 ml (∼40% of total red blood cell volume) with Oxyglobin solution, the red blood cell resistance to NO was greatly reduced. Therefore, the large percentage increase in both DLNO and the ratio of DLNO-to-DLCO between baseline and after exchange transfusion (30 ml/kg) is seen with no change in DLCO. This directly demonstrates a finite blood transfer conductance of NO (ΘNO) in vivo. Data reproduced from Borland and colleagues (7).Download figureDownload PowerPointWhat are the clinical implications of this study? First, although ΘNO is finite, DLNO does not need to be adjusted unless [Hb] is Volume 108Issue 5May 2010Pages 1027-1029 Copyright & PermissionsCopyright © 2010 the American Physiological Societyhttps://doi.org/10.1152/japplphysiol.00240.2010PubMed20224003History Published online 1 May 2010 Published in print 1 May 2010 Metrics

Referência(s)